Abeona Therapeutics (ABEO) Stock Price, Quote, News & History

Comments

Abeona Therapeutics Inc (ABEO) Stock Price, Quote, News & History

ABEONASDAQ

Trade with Public

$5.40

0.224.25%

At close: Feb 24, 4:00 PM EST

$5.15

-0.25-4.63%

After Hours: 7:20 AM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$5.20

Close

$5.40

Volume / Avg.

1.75M / 1.18M

Day Range

$5.16 - $5.43

52 Wk Range

3.93 - 7.54

Market Cap

$279.09M

P/E Ratio

4.28

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

28.2%

Days to Cover

10.36

Recent Abeona Therapeutics Inc News

PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease

Abeona's Zevaskyn secures timely FDA nod, priced at $3.1 million, with 2025 sales now forecast at $31.6 million and peak U.S. revenue projected at $600 million.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-74.93M

Investing Cash Flow (TTM)

114.35M

Financing Cash Flow (TTM)

27.74M

Free Cash Flow (TTM)

-82.36M

Capital Expenditure (TTM)

-7.43M

Net Change in Cash (TTM)

67.16M

Analyst Trends and Forecast

1

Oct 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$97.70M

PE Ratio (TTM)

4.28

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

796.50

PB Ratio (TTM)

1.64

Earnings Yield % (TTM)

23.36%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

1.09

Price / EBITDA (TTM)

3.55

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.16

Company Debt

Total Debt

$19.75M

LT Debt

$10.86M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$82.88M

Debt to Equity

0.14

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.20

Close

$5.40

Volume / Avg.

1.75M / 1.18M

Day Range

$5.16 - $5.43

52 Wk Range

3.93 - 7.54

Market Cap

$279.09M

P/E Ratio

4.28

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

28.2%

Days to Cover

10.36

About

Sector

Health Care

Industry

Biotechnology

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engi...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Abeona Therapeutics (ABEO) stock?

A

You can purchase shares of Abeona Therapeutics (NASDAQ:ABEO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Abeona Therapeutics (ABEO) competitors?

A

Other companies in Abeona Therapeutics’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Burning Rock Biotech Ltd (NASDAQ:BNR), Immuneering Corp (NASDAQ:IMRX), Palisade Bio Inc (NASDAQ:PALI) and AC Immune SA (NASDAQ:ACIU).

Q

What is the forecast, or price target, for Abeona Therapeutics (ABEO) stock?

A

Abeona Therapeutics has a consensus price target of $18.43.

Q

What is the current price for Abeona Therapeutics (ABEO)?

A

The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $5.15 last updated February 24, 2026 at 7:20 AM EST.

Q

Does Abeona Therapeutics (ABEO) pay a dividend?

A

There are no upcoming dividends for Abeona Therapeutics.

Q

When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?

A

Abeona Therapeutics does not have any upcoming earnings scheduled.

Q

Is Abeona Therapeutics (ABEO) going to split?

A

There is no upcoming split for Abeona Therapeutics.

Q

What sector and industry does Abeona Therapeutics (ABEO) operate in?

A

Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Burning Rock Biotech Ltd

Enlivex Therapeutics Ltd

NASDAQ:ENLV

$1.15

%

Silence Therapeutics PLC

NASDAQ:SLN

$5.35

0.38%

Fennec Pharmaceuticals Inc

NASDAQ:FENC

$8.91

%

Key Statistics

Open

$5.20

Close

$5.40

Volume / Avg.

1.75M / 1.18M

Day Range

$5.16 - $5.43

52 Wk Range

3.93 - 7.54

Market Cap

$279.09M

P/E Ratio

4.28

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

28.2%

Days to Cover

10.36

Recent Abeona Therapeutics Inc News

PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease

Abeona's Zevaskyn secures timely FDA nod, priced at $3.1 million, with 2025 sales now forecast at $31.6 million and peak U.S. revenue projected at $600 million.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-74.93M

Investing Cash Flow (TTM)

114.35M

Financing Cash Flow (TTM)

27.74M

Free Cash Flow (TTM)

-82.36M

Capital Expenditure (TTM)

-7.43M

Net Change in Cash (TTM)

67.16M

Analyst Trends and Forecast

1

Oct 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$97.70M

PE Ratio (TTM)

4.28

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

796.50

PB Ratio (TTM)

1.64

Earnings Yield % (TTM)

23.36%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

1.09

Price / EBITDA (TTM)

3.55

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.16

Company Debt

Total Debt

$19.75M

LT Debt

$10.86M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$82.88M

Debt to Equity

0.14

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.20

Close

$5.40

Volume / Avg.

1.75M / 1.18M

Day Range

$5.16 - $5.43

52 Wk Range

3.93 - 7.54

Market Cap

$279.09M

P/E Ratio

4.28

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

28.2%

Days to Cover

10.36

About

Sector

Health Care

Industry

Biotechnology

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engi...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry